Valo Therapeutics Oy
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer (NCT05492682) | Valo Therapeutics Oy | 2023-02-02 |
Track Valo Therapeutics Oy automatically
Every clearance here is in the API, with alerts when new ones post.